Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18694 | 473 | 27.4 | 70% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SQUAMOUS CELL CARCINOMA ANTIGEN | Author keyword | 47 | 51% | 14% | 66 |
| 2 | SCC ANTIGEN | Author keyword | 13 | 55% | 3% | 16 |
| 3 | SERPINB3 | Author keyword | 12 | 75% | 2% | 9 |
| 4 | SQUAMOUS CELL CARCINOMA ANTIGEN 1 | Author keyword | 9 | 64% | 2% | 9 |
| 5 | SCCA2 | Author keyword | 9 | 83% | 1% | 5 |
| 6 | SCCA IGM | Author keyword | 8 | 100% | 1% | 5 |
| 7 | SQUAMOUS CELL CARCINOMA ANTIGEN 2 | Author keyword | 8 | 100% | 1% | 5 |
| 8 | SCC AG | Author keyword | 8 | 48% | 3% | 12 |
| 9 | SCCA1 | Author keyword | 5 | 63% | 1% | 5 |
| 10 | SCCA | Author keyword | 4 | 42% | 2% | 8 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SQUAMOUS CELL CARCINOMA ANTIGEN | 47 | 51% | 14% | 66 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN |
| 2 | SCC ANTIGEN | 13 | 55% | 3% | 16 | Search SCC+ANTIGEN | Search SCC+ANTIGEN |
| 3 | SERPINB3 | 12 | 75% | 2% | 9 | Search SERPINB3 | Search SERPINB3 |
| 4 | SQUAMOUS CELL CARCINOMA ANTIGEN 1 | 9 | 64% | 2% | 9 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+1 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+1 |
| 5 | SCCA2 | 9 | 83% | 1% | 5 | Search SCCA2 | Search SCCA2 |
| 6 | SCCA IGM | 8 | 100% | 1% | 5 | Search SCCA+IGM | Search SCCA+IGM |
| 7 | SQUAMOUS CELL CARCINOMA ANTIGEN 2 | 8 | 100% | 1% | 5 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+2 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+2 |
| 8 | SCC AG | 8 | 48% | 3% | 12 | Search SCC+AG | Search SCC+AG |
| 9 | SCCA1 | 5 | 63% | 1% | 5 | Search SCCA1 | Search SCCA1 |
| 10 | SCCA | 4 | 42% | 2% | 8 | Search SCCA | Search SCCA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SCC ANTIGEN | 52 | 67% | 10% | 47 |
| 2 | TA 4 | 52 | 77% | 8% | 36 |
| 3 | TUMOR ASSOCIATED SERPIN | 6 | 100% | 1% | 4 |
| 4 | TUMOR MARKERS SCCA1 | 6 | 100% | 1% | 4 |
| 5 | TUMOR ANTIGEN 4 | 4 | 75% | 1% | 3 |
| 6 | TUMOR MARKERS CA 125 | 4 | 75% | 1% | 3 |
| 7 | 18Q213 | 4 | 56% | 1% | 5 |
| 8 | CELL CARCINOMA ANTIGEN | 4 | 23% | 3% | 14 |
| 9 | SCCA | 3 | 100% | 1% | 3 |
| 10 | CARCINOMA ANTIGEN GENE | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature | 2008 | 47 | 100 | 54% |
| Serpins, Immunity and Autoimmunity: Old Molecules, New Functions | 2013 | 8 | 85 | 14% |
| Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time? | 2015 | 0 | 31 | 71% |
| Role of SERPINB3 in hepatocellular carcinoma | 2014 | 0 | 34 | 65% |
| HUMAN SCCA SERPINS INHIBIT STAPHYLOCOCCAL CYSTEINE PROTEASES BY FORMING CLASSIC "SERPIN-LIKE" COVALENT COMPLEXES | 2011 | 2 | 21 | 38% |
| Cervical cancer: Biomarkers for diagnosis and treatment | 2015 | 0 | 36 | 33% |
| Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family | 2008 | 25 | 98 | 14% |
| Immunology of Gynecologic Neoplasms: Analysis of the Prognostic Significance of the Immune Status | 2009 | 11 | 316 | 6% |
| TUMOR-MARKERS IN GYNECOLOGIC CANCER | 1992 | 16 | 22 | 9% |
| DISTRIBUTION OF EPITHELIAL ANTIGENS IN THE HUMAN UTERINE CERVIX - A REVIEW | 1989 | 3 | 74 | 12% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CENT BIOMED EDUC | 1 | 20% | 0.8% | 4 |
| 2 | REPROD PEDIAT INFECT SCI | 1 | 20% | 0.8% | 4 |
| 3 | INTERUNIV LIVER PATHOPHYSIOL | 1 | 33% | 0.4% | 2 |
| 4 | CELL BIOL GASTROENTEROL NUTR | 1 | 50% | 0.2% | 1 |
| 5 | DR ADOLF KLARA BRETTLER MOL PHARMACOL | 1 | 50% | 0.2% | 1 |
| 6 | HLTH SCI CYTOL | 1 | 50% | 0.2% | 1 |
| 7 | PHYSIOL GASTROENTEROL NUTR | 1 | 50% | 0.2% | 1 |
| 8 | SIOPEL TUMOR BANKING PROGRAM | 1 | 50% | 0.2% | 1 |
| 9 | TALEGHANI TEACHING HOSP | 1 | 50% | 0.2% | 1 |
| 10 | DIAGNOST MED SCI SPECIAL THER IES | 1 | 10% | 1.3% | 6 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000284809 | CYFRA 21 1//CYTOKERATIN 19 FRAGMENTS//PROGRP |
| 2 | 0.0000198150 | MEGSIN//SERPINB2//PAI 2 |
| 3 | 0.0000111559 | CA 125//HE4//HUMAN EPIDIDYMIS PROTEIN 4 |
| 4 | 0.0000093780 | MASPIN//SERPINB5//SERPIN B5 |
| 5 | 0.0000076831 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
| 6 | 0.0000074703 | CA 15 3//CA 153//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN |
| 7 | 0.0000069583 | CERVICAL CANCER//CERVIX CANCER//LOCALLY ADVANCED CERVICAL CANCER |
| 8 | 0.0000063521 | UTERINE NEOPLASMS MR//PET DIAG//UTERINE NEOPLASMS STAGING |
| 9 | 0.0000058789 | DES GAMMA CARBOXY PROTHROMBIN//GOLGI PROTEIN 73//GP73 |
| 10 | 0.0000044737 | CA 19 9//CA19 9//SPAN 1 |